Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells

High-glucose increases NADPH oxidase 4 (NOX4) expression, reactive oxygen species generation, and matrix protein synthesis by inhibiting AMP-activated protein kinase (AMPK) in renal cells. Because hydrogen sulfide (H2S) inhibits high glucose-induced matrix protein increase by activating AMPK in renal cells, we examined whether H2S inhibits high glucose-induced expression of NOX4 and matrix protein and whether H2S and NO pathways are integrated. High glucose increased NOX4 expression and activity at 24 h in renal proximal tubular epithelial cells, which was inhibited by sodium hydrosulfide (NaHS), a source of H2S. High glucose decreased AMPK phosphorylation and activity, which was restored by NaHS. Compound C, an AMPK inhibitor, prevented NaHS inhibition of high glucose-induced NOX4 expression. NaHS inhibition of high glucose-induced NOX4 expression was abrogated by N(ω)-nitro-l-arginine methyl ester, an inhibitor of NOS. NaHS unexpectedly augmented the expression of inducible NOS (iNOS) but not endothelial NOS. iNOS siRNA and 1400W, a selective iNOS inhibitor, abolished the ameliorative effects of NaHS on high glucose-induced NOX4 expression, reactive oxygen species generation, and, matrix laminin expression. Thus, H2S recruits iNOS to generate NO to inhibit high glucose-induced NOX4 expression, oxidative stress, and matrix protein accumulation in renal epithelial cells; the two gasotransmitters H2S and NO and their interaction may serve as therapeutic targets in diabetic kidney disease.

[1]  N. Tamimi,et al.  Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.

[2]  Jessica Pham,et al.  Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[3]  H. Schmidt,et al.  Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy , 2016, Diabetologia.

[4]  H. Abboud,et al.  Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. , 2015, American journal of physiology. Renal physiology.

[5]  D. Féliers,et al.  Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes* , 2015, The Journal of Biological Chemistry.

[6]  S. Tyagi,et al.  Hydrogen Sulfide Epigenetically Attenuates Homocysteine‐Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells , 2015, Journal of cellular physiology.

[7]  Sa Shi,et al.  Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection , 2014, Molecular and Cellular Biochemistry.

[8]  H. Schmidt,et al.  Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy , 2014, Physiological reports.

[9]  Huan Wang,et al.  HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury , 2014, PloS one.

[10]  Xiaoping Zhou,et al.  Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model , 2014, The Journal of Biological Chemistry.

[11]  Qian Huang,et al.  Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose-Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells , 2014, PloS one.

[12]  R. Touyz,et al.  Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[13]  Rui Wang Gasotransmitters: growing pains and joys. , 2014, Trends in biochemical sciences.

[14]  G. Tonolo,et al.  Tubulointerstitial disease in diabetic nephropathy , 2014, International journal of nephrology and renovascular disease.

[15]  G. Dusting,et al.  NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses , 2014, Redox biology.

[16]  K. Block,et al.  Nox as a target for diabetic complications. , 2013, Clinical science.

[17]  A. Eid,et al.  Nox4 NADPH Oxidase Mediates Peroxynitrite-dependent Uncoupling of Endothelial Nitric-oxide Synthase and Fibronectin Expression in Response to Angiotensin II , 2013, The Journal of Biological Chemistry.

[18]  K. Block,et al.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? , 2013, Free radical biology & medicine.

[19]  A. Eid,et al.  Sestrin 2 and AMPK Connect Hyperglycemia to Nox4-Dependent Endothelial Nitric Oxide Synthase Uncoupling and Matrix Protein Expression , 2013, Molecular and Cellular Biology.

[20]  L. Rosivall,et al.  Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  J. Kim,et al.  AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. , 2013, American journal of physiology. Renal physiology.

[22]  R. Touyz,et al.  Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. , 2013, Clinical science.

[23]  H. Abboud,et al.  Transforming Growth Factor β Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy* , 2013, The Journal of Biological Chemistry.

[24]  Eva Dizin,et al.  NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. , 2012, Journal of the American Society of Nephrology : JASN.

[25]  Oliver Jung,et al.  Role of Nox4 in murine models of kidney disease. , 2012, Free radical biology & medicine.

[26]  Y. Yuzawa,et al.  Distribution of hydrogen sulfide (H2S)-producing enzymes and the roles of the H2S donor sodium hydrosulfide in diabetic nephropathy , 2012, Clinical and Experimental Nephrology.

[27]  Rui Wang Shared signaling pathways among gasotransmitters , 2012, Proceedings of the National Academy of Sciences.

[28]  A. Papapetropoulos,et al.  Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation , 2012, Proceedings of the National Academy of Sciences.

[29]  M. A. Moseley,et al.  Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. , 2012, Free radical biology & medicine.

[30]  H. Abboud,et al.  Hydrogen Sulfide Inhibits High Glucose-induced Matrix Protein Synthesis by Activating AMP-activated Protein Kinase in Renal Epithelial Cells*♦ , 2011, The Journal of Biological Chemistry.

[31]  Yunchao Su,et al.  Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. , 2011, Antioxidants & redox signaling.

[32]  A. Papapetropoulos,et al.  Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function , 2011, Proceedings of the National Academy of Sciences.

[33]  Yu Huang,et al.  Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  H. Abboud,et al.  AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes* , 2010, The Journal of Biological Chemistry.

[35]  P. Asfar,et al.  Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats , 2010, Critical care.

[36]  T. Murphy,et al.  PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[37]  S. Jha,et al.  Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice , 2010, Circulation.

[38]  T. Murphy,et al.  PPARγ regulates hypoxia‐induced Nox4 expression in human pulmonary artery smooth muscle cells through NF‐κB , 2010 .

[39]  A. Abbate,et al.  Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G–Dependent Generation of Hydrogen Sulfide , 2009, Circulation.

[40]  S. Jha,et al.  Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling , 2009, Circulation research.

[41]  M. Carraway,et al.  Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 , 2008, Circulation research.

[42]  S. Snyder,et al.  H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase , 2008, Science.

[43]  J. Moon,et al.  Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats , 2008, American Journal of Nephrology.

[44]  B. Falkner,et al.  Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.

[45]  G. Dusting,et al.  Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. , 2007, Cardiovascular research.

[46]  M. Gannon,et al.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. , 2007, The American journal of pathology.

[47]  B. Viollet,et al.  A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.

[48]  R. Harris,et al.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. , 2006, Journal of the American Society of Nephrology : JASN.

[49]  H. Abboud,et al.  Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney* , 2005, Journal of Biological Chemistry.

[50]  B. Halliwell,et al.  The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? , 2004, Journal of neurochemistry.

[51]  Samantha A. Tavener,et al.  Complexity of Inducible Nitric Oxide Synthase: Cellular Source Determines Benefit Versus Toxicity , 2003, Circulation.

[52]  Paul L Huang,et al.  Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney* , 2003, Journal of Biological Chemistry.

[53]  J. Sanes,et al.  Regulation of renal laminin in mice with type II diabetes. , 1999, Journal of the American Society of Nephrology : JASN.

[54]  H. Trachtman,et al.  Chronic diabetic nephropathy: role of inducible nitric oxide synthase , 2002, Pediatric Nephrology.

[55]  Y. Goto,et al.  The FASEB Journal express article 10.1096/fj.04-1815fje. Published online May 20, 2004. Hydrogen sulfide protects neurons from oxidative stress , 2022 .